DXR Projected Dividend Yield

Daxor Corp. ( NASDAQ : DXR )

Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. Co. has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at hospital centers across the U.S., enhancing hospital performance metrics in a range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care.

27 YEAR PERFORMANCE RESULTS